 |
 |
 |
DuPont Streamlines Organization and Names New
Leadership Team

DuPont has announced its plans to streamline its
organization and changes to its leadership team. The
actions support its sharpened focus on meeting
market demands, environmental protection, decreased
dependence on fossil fuels and growth of emerging
markets. In addition, the company plans to
strengthen alignment with both customers and
markets, drive disciplined scientific innovation
directly from market needs and increase transparency
and accountability with a simplified organization.
DuPont’s more streamlined organization includes
three key components. First, five group vice
president positions were eliminated along with the
existing support structure associated with the
platforms that house the Company’s businesses. Next,
DuPont’s 23 businesses were consolidated down to 14,
with a direct reporting line to the senior
leadership team. Each business has clear
accountability for profit –and-loss as well as cash
management. In addition, the 14 businesses were
streamlined to drive decision making closer to
customers by increasing regional business
responsibility and accountability.
Among the many personnel changes made, the company
reported that effective November 1, Nicholas
Fanandakis will succeed as Chief Financial Officer,
replacing current CFO Jeffrey Keefer. Keefer will
move to overseeing the performance coatings
business, corporate strategy development process,
and overall cost and working capital productivity
efforts. Effective September 30, Richard Goodmanson,
COO, will retire and his responsibilities will be
shared among the company's four executive vice
presidents, the CFO and the CEO. In addition to
these appointments, the presidents for the newly
organized 14 businesses were also announced.
|
 |
 |
 |
 |
 |
|
|
 |
 |
 |
Why Do Leaves
Change Color in the Fall?
While the chemicals
found in some fruits and vegetables remain
hidden during the summer, the cooler
temperatures of fall halt the production of
green, allowing the colors to take the
stage. Scientists have focused on just how
leaves get ready for the annual fall show.
While the molecules responsible for the
familiar oranges and yellows are understood,
the vibrant reds produced are still
intriguing.
Green-tinted chlorophyll , which enables the
leaves to capture sunlight and produce
energy, is sensitive to the cold. Leaves
stop producing chlorophyll in response to
the typical chilly weather and decreased
daylight of fall. An early frost will turn
off this production even quicker.
Carotenoids – the orange and yellow pigments
that already exist in the leaves- shine
through the leaves’ washed out green.
Less is known about the red hues that appear
in the northern forests. The red color comes
from anthocyanins. Unlike carotenoids, these
are only produced in the fall. These red
pigments behave like a sunscreen for the
tree, blocking out harmful radiation and
protecting the leaf from excess light. In
addition, they serve as antifreeze,
protecting the cells from freezing easily
and are also beneficial as antioxidants.
Stress in the environment such as freezing
temperatures, UV radiation, drought and
fungus cause trees to produce them as a
response.
Why would a tree put its energy towards
making anthocyanins, just when the leaf is
about to fall off? There has been
speculation that it could be something that
simply helps the tree deal with stress. It
may help the leaf stay on the tree a little
longer, providing a means for it to absorb
some of the good things before falling off.
Those resources could then be used by the
tree in the next growing season. Scientists
hope that studying anthocyanins will
enlighten them more about the degree to
which some trees are stressed. Such
information could provide a better idea of
environmental issues sooner.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
 |
 |
 |
SourceFinder
Makes Exhibition Experience More Productive
and Beneficial

Chemical
Information Services is proud
to announce the release of SourceFinder.
This collaboration between
Chemspec
and Chemical
Information Services offers
exhibitors and attendees a vast array of
valuable tools, aimed at making their
exhibition experience more worthwhile and
beneficial. The unique information resource
enables show participants to find the vital
information they need before, during and
after a show, utilizing powerful features
found in
Chemical Information Services’
network of database products. Attendees may
perform company, product, structure and CAS
number searches as well as locate the latest
industry news and organize vital show
information. SourceFinder is a unique
internet resource that provides a selection
of functions to assist exhibitors in putting
their best foot forward during the show,
enabling them to showcase their high-value
information and documentation to attendees.
SourceFinder will be available at the
following exhibitions in 2010:
• Chemspec
India - Mumbai, April 15th and 16th
• Chemspec
Europe - Berlin, June 9th and 10th
• Chemspec
Latin America - Mexico City, September
16th and 17th
• Chemspec
Middle East - Dubai, November 25th
and 26th

|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
EPA Approves Biocide Produced by Swan
Chemical
The U.S. Environmental
Protection Agency (EPA) has approved a
biocide used in boiler and cooling-water
systems and in industrial process water.
Thomas Swan & Co., Ltd., a chemicals
manufacturer based in Consett, England, is
producing Casacide T100, along with its U.S.
subsidiary, Swan Chemical, Inc., based in
Lyndhurst, New Jersey. Casacide T100 is
based on 2-(Thiocyanomethylthio)-benzothiazole
– TCMTB – and is the last of similar
chemicals to gain EPA approval. A
well-proven, broad-spectrum biocide,
Casacide T100 is used for microbiological
control in water treatment systems, as a
mold inhibitor, and as an anti-fungal
ingredient. The limited choice of suppliers
in the U.S. will provide a good market for
Casacide in the paper, paint, and
leather-tanning industries.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Crucell Receives
Funding for Influenza Antibody

Dutch biopharma company, Crucell, N.V. has
received a funding contract in the amount of
$40.7 million from the National Institute of
Allergy and Infectious Diseases (NIAID)/National
Institutes of Health (NIH). The contract is
aimed at advancing the development of
monoclonal antibodies for the treatment of
seasonal and pandemic influenza,
particularly the H1N1 influenza virus (swine
flu) and the Avian H5N1 virus (bird flu).
The contract may also provide an additional
awarded amount of $28.4 million, at NIH’s
discretion.
With recent reports of A/H1N1 oseltamivir
resistance occurring, this contract will
provide Crucell and its partners with the
funding to pursue a new approach for the
treatment of the disease. Oseltamivir (Tamiflu)
is the current first-line therapeutic
against H1N1 viruses. However, the newly
discovered antibodies have been shown to be
active against the seasonal and pandemic
H1N1 (swine flu) and Avian H5N1 (bird flu)
viruses, which are currently circulating in
Asia.
The development of unique human monoclonal
antibodies that have shown to protect
against seasonal and pandemic influenza
viruses, has confirmed the validity of
Crucell’s innovative antibody approach.
|
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
Entegrion
Awarded Navy Contracts
Entegrion, the life sciences company, has
been awarded two contracts by the U.S. Navy
to implement its proprietary technologies to
improve the safety and availability of
blood-derived products for treating combat
injuries. Blood component therapy has proven
essential in responding to traumatic injury.
Use of blood components are moving toward
earlier and more aggressive clinical
practice, however, availability of these
therapies are limited due to shelf-life and
storage requirements. Entegrion’s
technologies are producing blood-derived
products that do not require refrigeration,
have fewer pathogens, and can be stored for
longer periods.
The advanced development of Stasix®, a
dehydrated platelet-derived hemostatic
agent, is being funded by the first
contract. Stasix® allows for reconstitution
and transfusion to control non-compressible
internal bleeding.
An additional $2 million contract will fund
the advanced development of Resusix®,
dehydrated, pathogen-reduced, fresh human
plasma. Resusix® is used for infusion in
trauma patients; expanding blood volume,
correcting abnormal coagulation function,
and supporting hemostasis.
The U.S. Navy’s funding marks the fourth
major contract Entegrion has received over
the last six years.
|
 |
 |
 |
 |
Dow Kokam
Receives Grant for Next Generation Battery
Production
Dow Kokam has been awarded a $161 million
federal grant from the U.S. Department of
Energy (DOE). The product of a joint venture
between Dow Chemical Company and Townsend
Kokam LLC, the company will develop a new
generation of high-power battery technology
to supply the automotive industry. The
funding will be used to establish
manufacturing operations, including the
construction of an 800,000 square foot
facility in Midland, Mich. Construction is
expected to commence by late October of this
year with battery production slated to begin
in early 2011. The facility will employ up
to 800 people. Once complete, the Midland
facility is expected to produce enough
batteries to supply 60,000 hybrid or
electric vehicles per year. The DOE grant is
subject to final agreement on terms between
the DOE and Dow Kokam, which is anticipated
by early fall.
|
 |
 |
 |
|
|
 |
 |
 |
Monsanto EVP and
CFO to Retire
Leading global provider of technology-based
solutions and agricultural products,
Monsanto Company announced that Executive
Vice President and Chief Financial Officer
Terry Crews will retire from the company
effective Nov. 30, 2009. Executive Vice
President of Strategy and Operations, Carl
Casale has been named as Crews’ successor
effective Sept. 1, 2009. Crews will serve as
Special Assistant to the CEO through Nov.
30, 2009.

Researcher
Receives Grace Award

Ranjit Kumar has been recognized by W.R.
Grace & Co. with the 2008 Grace Award for
Technical Excellence. The R&D Fellow
received the award for his work to develop
novel fluid catalytic cracking (FCC)
catalysts that reduce the impact of metals
during the processing of crude oil.
Petroleum refineries use catalysts to
“crack” the large hydrocarbon molecules in
distilled crude oil in order to produce
transportation fuels, such as gasoline and
diesel. The refining industry’s focus in
recent years has been on processing larger
amounts of heavy crude oil in FCC units.
Heavy crude presents a special challenge; it
typically contains high levels of
contaminant metals like vanadium. This
lowers the effectiveness of catalysts and
generates more light gases and residue, at
the expense of valuable products like
gasoline. Ranjit’s accomplishment involves
the identification of a process for
incorporating vanadium trapping capability
into FCC catalysts. This technology is
currently used in about half of the FCC
catalysts manufactured at Grace, with
significant impact on the industry in
general. Ranjit joined Grace in 1984 and is
currently an R&D Fellow for Grace Davison
Refining Technologies.

NOVA Chemicals CFO to Retire
NOVA Chemicals recently announced that
Senior Vice President and Chief Financial
Officer Larry A. MacDonald will retire
effective December 31, 2009. MacDonald has
been with the company for more than 30
years. During his tenure, he held various
leadership positions and was a member of
NOVA’s Executive Leadership Team. Through
the end of the year, MacDonald will continue
to focus on the company’s refinancing plans
and the transition of business activities
under their new IPIC ownership.

Johan van
Walsem Appointed Vice President of
Commercial Development for Metabolix
Metabolix, Inc. has appointed Johan van
Walsem Vice President of Commercial
Development. Mr. van Walsem will be
responsible for the development of the
company’s business strategies and commercial
development for its non-Telles activities,
primarily crop and microbial fermentation
technology programs. Mr. van Walsem has
extensive experience in nearly every aspect
of bulk and specialty biochemical product
commercialization. He returns to Metabolix
following a 16 month period as Senior Vice
President, R&D and Bioprocessing at Joule
Biotechnologies, a clean technology start-up
in Cambridge.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
 |
 |
 |
Pacific
Biosciences Raises Additional Funds
Menlo Park, Calif.-based Pacific
Biosciences, Inc. recently reported raising
an additional $68 million in financing.
Financing for the DNA sequencing technology
company comes from a combination of both new
and previous investors, including U.K.-based
Wellcome Trust, St. Louis, Mo.-based
Monsanto and Palo Alto, Calif.-based Sutter
Hill Ventures. Pacific Biosciences future
plans include the launch of the commercial
version of its SMRT Sequencing System in the
second half of next year. Founded in 2004,
the company received an Advanced Sequencing
Technology Award grant from the National
Human Genome Research Institute to develop
the $1,000 genome.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Calcium Carbide
Production Stopped at China Plant
A subsidiary of China National Chemical
Corporation has stopped production of
calcium carbide because of low profits.
Hunan Xiangwei Company Ltd’s 65,000
tonne/year plant had been in operation more
than 30 years. The company, located in Xupu
County, Hunan Province, closed on August 9.
It had been purchasing calcium carbide
rather than producing because the price gap
had reached CNY600/tonne. A better
production structure can now be chosen for
the company that produces vinyl acetate,
polyvinyl alcohol (PVA), and PVA fiber.
|
 |
 |
 |
 |
Oxea Acquires
Esters Plant

Oxea announced that it had completed its
acquisition of the Amsterdam Esters Plant in
Amsterdam, Netherlands, on August 1, 2009.
Acquiring the esters plant from ExxonMobil
Chemical Holland B.V. will strengthen the
global chemical company’s position in
specialty chemicals, as well as broadening
its application basis and provide an
extension of its value chain.
While additional expertise will be brought
in to the existing operations of the plant,
the company assures it will keep all
employees in Amsterdam. New base materials
will also be brought in for ester
productions, making Oxea more independent
and improving its flexibility.
Esters are organic compounds used in the
production of lubricants, flavorings,
cosmetics, coatings, and pharmaceutical
products. Oxea also supplies solvents,
polyols, and oxo-derivatives used in these
areas, as well as for fragrances, plastics,
and printing inks.
|
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
Trevira to
Cut Workforce by 300
As part of Trevira’s restructuring effort to
sell the insolvent textile fiber and
polyester producer to investors, it is
expecting to cut 17% of its workforce –
about 300 jobs. Most of the job cuts would
take place in production and administration.
The Germany-based company filed for
insolvency in June and hopes to sell its
Germany and Poland operations to investors.
In addition, a buyout by management is being
negotiated for Trevira’s operations in
Denmark and Belgium.
Trevira is part of Reliance Industries, an
Indian petrochemicals company which bought
Trevira in 2004. Previously, it was part of
Hoechst, the German pharmaceuticals and
chemicals company, which formed Aventis
after a merger with French company
Rhone-Poulenc.
|
 |
 |
 |
 |
Hovione Sales
Increase for Fiscal Year

Hovione recently
announced a growth in consolidated sales of
21% for the fiscal year ended March 31,
2009, amounting to $125.5 million. In 2008,
the active pharmaceutical ingredient (API)
manufacturer negotiated the acquisition of a
Pfizer manufacturing facility, located in
Cork, Ireland.
This facility offers a state-of-the-art
spray drying building, as well as a
world-class production capacity, providing
an increased capacity to meet its clients
growing production requirements.
Additionally, Hovione will have the ability
to manage the growing opportunities for
outsourcing in Large Pharma.
Furthermore, Hovione invested heavily in
production links and particle design
technologies in both Hovione Portugal and
Hisyn, China.
Hovione marks 50 years of
experience in API development and compliant
manufacture in 2009, with four FDA inspected
sites in U.S.A., Portugal, China, and
Ireland.
|
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
|
|
 |
 |
Cognis Develops
New Emulsifier Compound for Baked Goods
Cognis
Nutrition & Health recently launched a safe,
easy, all-in-one solution to meet the needs
of cake gel manufacturers. The global
supplier of innovative specialty chemicals
and nutritional ingredients has launched its
Lamemul GP 84-6 - a new, high-performance
emulsifier compound. The single product is
used in place of the multitude of different
emulsifiers used previously, thereby
simplifying the production process, making
it easier, safer, more reliable and
guaranteeing consistently outstanding
quality. The end result is high-quality
baked products with a long shelf-life,
making life easier for both manufacturers
and consumers.
|
 |
 |
 |
 |

|
 |
 |
| |
|
Clariant
Launches Web Presence for Defoamers
Clariant recently launched a comprehensive
web presence for its newly acquired
defoamers business. Through web pages found
at www.defoamers.us , customers and
prospects can become better acquainted with
Clariant’s know-how and family of
technologies for more than 100 different
foam-control products, silicone fluids and
emulsions in end-use markets. Visitors to
the Defoamers web pages can download product
bulletins, request product samples, ask
questions, make general inquiries and send
email directly to contacts for the business.

Clariant acquired the XL Performance
Chemicals from FibroChem LLC and its
affiliates in May. The business opportunity
offered more than a $2billion global market
which is growing annually at a rate of
4-to-5 percent. Manufacturing will continue
to be centered in the U.S. at a facility in
Greenville, S.C. operated under a toll
agreement, with the potential for Clariant
to transfer manufacturing to its own
strategically located plants elsewhere in
the world as market penetration and growth
increases.
|
|
|
 |
 |

|
 |
 |
|
|
 |
![]() |
Diabetes Drug
Approved in U.S.
Januvia, Germany’s best-selling treatment
for adult diabetes will be competing with a
new pill AstraZeneca has developed in
partnership with Bristol-Myers Squibb.
AstraZeneca received approval from the FDA
in America for Onglyza, making it the first
new pill launched by AstraZeneca in the U.S.
since 2003 when it began selling Crestor,
its anti-cholesterol treatment. Onglyza
treats Type II diabetes, a condition an
estimated 24 million people suffer from
(approximately 10% of the U.S. population).
Expected to achieve $1 billion in annual
sales, the once-a-day pill’s approval is
especially significant in America because it
is the largest healthcare market in the
world.
Dapagliflozin, a second diabetes treatment,
is also being tested by AstraZeneca and
Bristol-Myers Squibb.
|
 |
 |
 |
 |

|
 |
 |
|
|
|
Par
Pharmaceutical & Aveva Drug Gain Final
Approval to Market Generic Drug
Aveva Drug Delivery Systems, licensing
partner for Par Pharmaceuticals, has
received final FDA approval for its
Abbreviated New Drug Application for a
clonidine transdermal system. Clonidine TDS
is a generic version of Boehringer
Ingelheim's Catapres TTS® and is the first
generic seven-day patch indicated in the
treatment of hypertension. According to IMS
Health data, annual sales in the U.S. for
Catapres TTS® were approximately $297M. Par
expects to ship clonidine TDS to the trade
in the near future. Terms of the agreement
provide Par with the exclusive rights to
market, sell and distribute Aveva's
clonidine TDS in the U.S. Aveva will
manufacture the product and the companies
will share profits from the sales of the
product.
|
|
|
 |
 |

|
 |
 |
|
|
|
FDA Approves
Another Cholesterol Drug in U.S.
The FDA has approved another cholesterol
drug in the U.S. Kowa Pharmaceuticals
America reacquired the rights to sell the
generic drug pitavastatin under the brand
name Livalo. Novartis gave up the rights to
pitavastatin in 2005 when it made the
decision to focus on conditions such as
metabolic disorders and hypertension. The
change cost the pharmaceutical company
$266m.
While most statins carry a risk when taken
with other drugs such as the blood thinner,
warfarin, Livalo is metabolized differently.
Therefore, patients do not experience the
same interactions that can be a concern
while taking multiple medications.
Launch of the drug in the U.S. is planned
for early 2010.
|
|
|
 |
 |

|
 |
 |
|
|
|
Dermik
Laboratories Offers Skin Care Option
Dermik
Laboratories announced the availability of
the BenzaClin carekit (clindamycin
1%-benzoyl peroxide 5% gel), prescribed for
patients with acne. The Sanofi-Aventis U.S.
business offers this unique option to those
who want to add a moisturizing agent to
their skin care therapy regimen. Acne
affects nearly 80% of people between the
ages of 12 and 24.
BenzaClin features the 50g BenzaClin PUMP
with 20 ampoules of the topical hyaluronic
acid cosmetic product, Viscontour Serum. It
offers a convenient way of moisturizing,
acting as a natural moisture reservoir for
the skin.
BenzaClin offers physicians another choice
of what to provide patients seeking moisture
care, while still treating their acne. Both
are now available in one easy to write
prescription.
Patients can choose the unique and
convenient BenzaClin 50g PUMP or the
BenzaClin 25g jar. It has been shown to
reduce acne in as little as two weeks,
combining the acne-fighting substances of
clindamycin and benzoyl peroxide.
|
|
|
 |
 |

|
 |
 |
 |
|
|
 |
 |
China Green
Agriculture Launches New Fertilizer Products
China Green Agriculture,
Inc. a leading producer and distributor of
humic acid ("HA") based liquid compound
fertilizer through its wholly owned
subsidiary, Shaanxi TechTeam Jinong Humic
Acid Product Co., Ltd., launched three new
liquid based fertilizer products in the
quarter ended June 30, 2009.
The first product, Dao Sheng is a product
specifically developed to strengthen the
immune system for transplanted rice
seedlings, protecting them from various
diseases while increasing output. The next
product, Jin Wang Ting can be applied to
crops in three different growing stages,
improving root system development,
strengthening vegetative parts, and
stimulating the flowering stage. The third
product, Xian Jian hinders bacterial growth
in the soil which leads to root degradation,
improving the survival rate of transplant
and grafted seedlings for melon while
increasing both sugar and vitamin content in
melon.
China Green Agriculture currently offers 134
different humic acid based liquid compound
fertilizers. Distribution is handled by the
company’s 530 individual distributors
covering 27 provinces in China and is
certified by the Chinese government as
"Green Food Production Materials".
|
 |
 |
 |
 |

|
 |
 |
|
|
|
Romania's Petrom
May Close Subsidiary

Doljchim Craiova, the chemical fertilizer
and methanol subsidiary of Romania’s Petrom,
may be forced to close at least temporarily,
possibly permanently. Majority-owned by
Austria’s OMV, Petrom has searched for a
partner to manage its plants, but is now
considering other options, including selling
its petrochemical unit, Arpechim, to
Romanian company Oltchim.
Doljchim Craiova is the sole producer of
chemical fertilizers in southwest Romania.
It has been producing urea, ammonia,
ammonium nitrate, calcium ammonium nitrate,
and nitric acid for more than 40 years.
However, its overall sales of chemical
fertilizers fell 37% the first half of 2009,
to 173,000 tonnes compared to the same
period last year. A 230,000 tonne/year
methanol plant is also part of Doljchim
Craiova.
|
|
|
|
|
|
 |
|
|
|
|
|
Monsanto R&D
Projects on Verge of Breakthrough
Monsanto, a U.S. agricultural firm, is
approaching an unprecedented technology
explosion that will double yields in their
three core crops. Several projects that will
improve corn, cotton, and soybean yields are
in the research and development pipeline
promising to deliver the types of products
growers are seeking.
There are seven new seed and biotechnology
projects aimed at generating $3 billion in
incremental gross income for Monsanto. As
part of their partnership with Germany’s
BASF, the drought-tolerant corn family; the
nitrogen-utilization corn family; and the
broad-acre, higher-yielding corn and soybean
families are included in the projects.
Monsanto is projecting an expansion of its
seeds and traits business at a 20% compound
annual growth rate from 2007 to 2012. The
company is committed to double its 2007
gross project by 2012, reaching $7.3 to $7.5
billion.
|
|
|
|
|
|
 |
|
|
 |
|
|
|
|
|
 |
 |
 |
Dow Coating
Materials Joins Forces with Getty
Conservation Institute and Tate
Dow Coating Materials (DCM), a business unit
of The Dow Chemical Company, has partnered
with Getty Conservation Institute (GCI) and
Tate as part of ongoing research to develop
more effective methods for cleaning works of
art created with acrylic paint. Dow is a
global leader in the manufacture of the base
latexes for acrylic house-paints, as well as
many raw materials used in house-paints,
cleaning products, fine art acrylic paints,
and conservation materials The company is
sharing its expertise in designing and
evaluating cleaning systems with scientists
seeking to preserve important works of art
made with acrylic paints from the last 50
years.
Findings from this collaborative effort are
expected to have far-reaching effects. Since
the 1960’s, acrylic media for works of art
have accounted for approximately 50 percent
of artist paint sales, with acrylic emulsion
products being the most commonly used
priming medium for modern canvases. The
initial research results from this effort
were presented in May 2009 during the
General Session of the American Institute
for Conservation’s 37th Annual Conference.
Since early 2008, GCI scientists have been
working with Dow research chemist Melinda
Keefe and Dr. Bronwyn Ormsby of Tate in
London to develop cleaning formulations for
the removal of dirt from artists’ acrylic
emulsion paint films. Dow’s unique High
Throughput Research (HTR) will be used to
identify potential cleaning solutions that
will effectively remove surface dirt without
altering or damaging the paint layers
beneath. HTR utilizes computer modeling and
robotics that dramatically reduce the time
required to explore and implement new
solutions.

PPG Introduces Single-Source Coating System

PPG Industries recently introduced its
VIVATI™ vacuum metalized coating system for
consumer products. This highly chromatic,
high-performance coating delivers new
aesthetics, increases production yields and
speeds up product launches. Vacuum metalized
coatings are used to place a thin metal
layer on plastic substrates, and they
decorate many hand-held devices in bright,
shiny colors. Such coatings are also used in
toys, personal computers, automotive trim,
sporting goods, decorative fixtures and many
other products. Manufacturers typically
purchase three coating layers – primer, base
coat and clear coat – from multiple
suppliers. The VIVATI™ coatings offer the
first integrated system from a single
supplier. As a single-source coating system,
VIVATI™ coatings enable manufacturers to
better control and manage the vacuum
metalizing process. The primer, base and
clear coats all come from one supplier,
working together for performance and
application. The end result is a larger
operating window with fewer mistakes and
higher production output. Manufacturers
realize increased yields and expedited
launches of new products and colors as a
result.
|
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
 |
|
|
 |
 |
 |
PolyMirae Offers
New PP for Use in Food Contact Applications
A new polypropylene (PP) resin suitable for
food containers has been developed by South
Korea-based PolyMirae Company Ltd., a joint
venture of LyondellBasell and Daelim.
Clyrell RC5056 is suitable for food
contact applications such as baby bottles
and containers, which is especially
significant with the level of alarm over
such containers made with Bisphenol-A. The
new PP resin possesses such characteristics
as high gloss, high chemical inertness
durability, resistance to high temperatures,
and transparency. The polypropylene resin
can withstand various processing methods
including injection molding, injection blow
molding, and injection stretch blow molding.
In addition, the resin is recyclable and
meets the food contact cooking requirements
established by the FDA.
Compared with a haze value of 18 in
the other standard PP random copolymers,
Clyrell RC5056’s easy processing provides an
attractive cost/performance ratio and a very
low haze value of 9. Additionally, it offers
a potential cycle time reduction of 10%. |
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
 |
 |
 |
Unemployment
Rises in German Plastics and Rubber Sectors
According to the Statistisches Bundesamt in
Wiesbaden, the plastics and rubber sector is
suffering due to the economic downturn.
Germany’s manufacturers recorded the highest
reduction in hours worked in June – an 11.5%
decline. In addition, a 4.2% decline in
employed workers was recorded compared with
June 2008 – down to 305,000. June marked the
sharpest year-on-year decline in the monthly
manufacturing employment data since December
2002.
Simona, the German thermoplastics firm, is
considering closing one production site due
to continued losses. Germany’s unemployment
is expected to rise sharply as
government-supported short-time work
programs expire. Chemicals and plastics
manufacturers have been using these programs
to cope with the economic downturn.
In contrast, Altana, Germany’s specialty
chemicals producer, has been ending
short-time work because order levels have
improved. Under short-time work, employers
reduce wages in line with reduced hours.
Workers are partly compensated for the loss
in wages by payments from government
unemployment insurance. A number of German
chemical producers have used the programs
recently, as means of coping with the
economic downturn.
|
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
 |
|
|
 |
|
|
|
|
|
|
|